SCM
OVID icon

Sterling Capital Management’s Ovid Therapeutics OVID Stock Holding History

Sterling Capital Management’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.49K Buy
+2,786
New +$7.19K ﹤0.01% 2385
2025
Q2 		– Sell
-61
Closed -$19 – 3358
2025
Q1 		$19 Hold
61
– – ﹤0.01% 3200
2024
Q4 		$57 Hold
61
– – ﹤0.01% 3207
2024
Q3 		$72 Buy
+61
New +$64 ﹤0.01% 3218

Other funds holding OVID

PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SFG
Sovereign Financial Group Stamford, Connecticut $654M AUM 32.34% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
BMC
Benin Management Corp Wilton, Connecticut $494M AUM 25.95% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $902M AUM 21.74% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Sterling Capital Management's OVID Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Ovid Therapeutics (OVID) in Q2 2026: 2,786 shares worth $7.49K. The stake represents ﹤0.01% of the portfolio and ranks #2385 among its holdings. This is a return to the name: Sterling Capital Management previously reported a position in OVID as recently as Q1 2025.

Sterling Capital Management first reported a position in OVID in Q3 2024 and has held it in 4 quarters since. 13 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • Sterling Capital Management held 2,786 shares of Ovid Therapeutics worth $7.49K as of Q2 2026.
  • Ovid Therapeutics was a new Sterling Capital Management position in Q2 2026.
  • Ovid Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2385 holding.
  • Sterling Capital Management first reported a position in Ovid Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • 13 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.